Alexandra Rose Bonner is a Cleveland, Ohio based neurologist who is specialized in Child Neurology. Active license number of Alexandra Rose Bonner is 35.147082 for Child Neurology in Ohio. Her current practice location is Cleveland Clinic 9500 Euclid Avenue/na-23, Cleveland. Patients can reach her at 216-444-2200. Alexandra Rose Bonner NPI number (Unique professional ID assigned by NPPES) is 1255836771. Alexandra Rose Bonner specializes in neurology with special skills in diagnosis and treatment of neurologic disorders of the neonatal period, infancy, early childhood, and adolescence.
Complete Profile:
Alexandra Rose Bonner speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1255836771
NPI Enumeration Date:
27 Mar, 2018
NPI Last Update On:
13 May, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Alexandra Rose Bonner are as mentioned below.
License Number
Specialization
State
Status
35.147082
Child Neurology
Ohio
Primary
Student in an Organized Health Care Education/Training Program
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Alexandra Rose Bonner Cleveland Clinic 9500 Euclid Avenue/na-23, Cleveland, Ohio
Zip:
44195-0001
Phone Number:
216-444-2200
Patients can reach Alexandra Rose Bonner at Cleveland Clinic 9500 Euclid Avenue/na-23, Cleveland, Ohio or can call to book an appointment on 216-444-2200.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.